{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:31:23Z","timestamp":1761532283452,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA006927"],"award-info":[{"award-number":["P30 CA006927"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.brachy.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:56:53Z","timestamp":1688086613000},"page":"586-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2195-9566","authenticated-orcid":false,"given":"Charles T","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9365-6591","authenticated-orcid":false,"given":"Olufela","family":"Koleoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-8064","authenticated-orcid":false,"given":"Mengying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iavor","family":"Veltchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Hallman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-317X","authenticated-orcid":false,"given":"Eric M","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4331-9164","authenticated-orcid":false,"given":"J. Karen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.06.003_bib0001","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1002\/cncr.25456","article-title":"Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer","volume":"116","author":"Cooperberg","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2023.06.003_bib0002","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11255-019-02114-4","article-title":"Salvage treatment for radio-recurrent prostate cancer: a review of literature with focus on recent advancements in image-guided focal salvage therapies","volume":"51","author":"Haj-Hamed","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0003","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A Systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0004","doi-asserted-by":"crossref","first-page":"681448","DOI":"10.3389\/fonc.2021.681448","article-title":"Salvage reirradiation options for locally recurrent prostate cancer: A systematic review","volume":"11","author":"Zhong","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2016.05.024","article-title":"Reirradiation of prostate cancer local failures after previous curative radiation therapy: Long-term outcome and tolerance","volume":"96","author":"Zilli","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0006","doi-asserted-by":"crossref","first-page":"E911","DOI":"10.1016\/j.ijrobp.2020.07.541","article-title":"Stereotactic body radiotherapy (SBRT) as salvage treatment for locally recurrent prostate cancer","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0007","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1016\/j.ijrobp.2015.07.1057","article-title":"Robotic SBRT for locally advanced prostate cancer recurrence following radiation therapy: Preliminary results of a single institution","volume":"93","author":"Leroy","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0008","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2006.10.012","article-title":"Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: The University of California-San Francisco experience","volume":"67","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0009","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2013.01.027","article-title":"Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes","volume":"86","author":"Chen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brachy.2016.09.008","article-title":"Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome","volume":"16","author":"Jiang","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.06.003_bib0011","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2019.09.006","article-title":"Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy","volume":"141","author":"Lopez","year":"2019","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.brachy.2023.06.003_bib0012","first-page":"1","article-title":"Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients","volume":"27","author":"van Son","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0013","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/j.prro.2022.05.018","article-title":"A prospective study of magnetic resonance imaging-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: Updated results of 30 patients","volume":"12","author":"Corkum","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0014","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brachy.2015.12.007","article-title":"Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy","volume":"15","author":"Yeh","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.06.003_bib0016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5114\/jcb.2019.82836","article-title":"Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space","volume":"11","author":"Chao","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.06.003_bib0017","first-page":"E533","article-title":"Reduction in rectal dose with the use of SpaceOAR hydrogel to treat prostate adenocarcinoma with HDR brachytherapy","volume":"46","author":"Baghwala","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0018","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.brachy.2017.11.006","article-title":"Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103","volume":"17","author":"Taggar","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.06.003_bib0019","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.brachy.2023.06.003_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brachy.2009.09.006","article-title":"Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with Cs-131 brachytherapy for prostate cancer","volume":"9","author":"Gokhale","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.06.003_bib0021","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jjco\/hyl133","article-title":"Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry","volume":"37","author":"Ohashi","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0022","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.prro.2021.04.007","article-title":"Salvage high-dose-rate brachytherapy for recurrent prostate cancer after definitive radiation","volume":"11","author":"Wu","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0023","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/jcb.2017.67456","article-title":"Use of ultrasound in image-guided high-dose-rate brachytherapy: Enumerations and arguments","volume":"9","author":"Banerjee","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.06.003_bib0024","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.radonc.2019.09.011","article-title":"MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial","volume":"141","author":"Alayed","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0025","doi-asserted-by":"crossref","first-page":"971344","DOI":"10.3389\/fonc.2022.971344","article-title":"MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer","volume":"12","author":"Menard","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0026","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1016\/j.ijrobp.2013.06.933","article-title":"Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy","volume":"87","author":"Price","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0027","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ijrobp.2005.08.042","article-title":"Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: Use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors","volume":"64","author":"Shah","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.06.003_bib0028","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/1754-9485.12945","article-title":"Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion","volume":"63","author":"Te Velde","year":"2019","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.06.003_bib0029","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/1754-9485.13179","article-title":"Dosimetric and clinical outcomes of SpaceOAR in men undergoing external beam radiation therapy for localized prostate cancer: A systematic review","volume":"65","author":"Babar","year":"2021","journal-title":"J Med Imaging Radiat Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:18:38Z","timestamp":1761531518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1538472123000818"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.06.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}